Abbott India Q4 Profit Jumps 28% on Strong Medicine Sales and Efficiency Gains

Abbott India Q4 Profit Jumps 28% on Strong Medicine Sales and Efficiency Gains   Robust demand in gastrointestinal and chronic care therapies propels Abbott India’s profit growth and revenue momentum in the March 2025 quarter.  Strong Q4 Numbers Reinforce Market … Continue reading Abbott India Q4 Profit Jumps 28% on Strong Medicine Sales and Efficiency Gains